Yonsei Technology Holdings
University-affiliated technology holdings company that manages technology transfer, establishes and supports university spin-out subsidiaries, operates investment funds, and runs commercialization and incubation programs to translate academic research into marketable products and companies.
Industries
Nr. of Employees
small (1-50)
Yonsei Technology Holdings
Services
End-to-end technology transfer including rights assignment, licensing, negotiations and post-transfer commercialization support.
Provision of tiered incubator spaces, office facilities and campus‑linked startup support programs.
Direct equity investments, private investment fund management and connections to venture capital networks.
Programs offering prototyping, mentoring, R&D grant matching and commercialization planning for promising technologies.
Invention evaluation, patent strategy development and dedicated patent office coordination for commercialization readiness.
End-to-end technology transfer including rights assignment, licensing, negotiations and post-transfer commercialization support.
Provision of tiered incubator spaces, office facilities and campus‑linked startup support programs.
Direct equity investments, private investment fund management and connections to venture capital networks.
Programs offering prototyping, mentoring, R&D grant matching and commercialization planning for promising technologies.
Invention evaluation, patent strategy development and dedicated patent office coordination for commercialization readiness.
Expertise Areas
- Technology commercialization
- Startup incubation and acceleration
- Intellectual property and patent strategy
- Fund operation and venture investment
Key Technologies
- mRNA therapeutics
- Antiviral drug discovery (viral RNA polymerase inhibitors)
- Neural electrode coatings and BCI-related interfaces
- Perovskite thin films
News & Updates
Memorandum of understanding to support joint projects, market entry for university spin-outs and collaboration in healthcare and cosmetics; includes an exclusive sales contract for a subsidiary estimated at ~3 billion KRW.
Agreement to jointly discover technologies, operate co-investment funds and plan overseas PoC programs for technology-based startups.
Announcement that a biotechnology subsidiary signed an MOU with a city and biotechnology center in Da Nang for development of a next-generation hair-loss therapeutic.
A university spin-out secured an exclusive sales contract in China valued at approximately 3 billion KRW as part of a market‑entry collaboration.
Memorandum of understanding to support joint projects, market entry for university spin-outs and collaboration in healthcare and cosmetics; includes an exclusive sales contract for a subsidiary estimated at ~3 billion KRW.
Agreement to jointly discover technologies, operate co-investment funds and plan overseas PoC programs for technology-based startups.
Announcement that a biotechnology subsidiary signed an MOU with a city and biotechnology center in Da Nang for development of a next-generation hair-loss therapeutic.
A university spin-out secured an exclusive sales contract in China valued at approximately 3 billion KRW as part of a market‑entry collaboration.